Galectin‐3 and N ‐acetylglucosamine promote myogenesis and improve skeletal muscle function in the mdx model of Duchenne muscular dystrophy
Authors:
Open Access
- 12 June 2018
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 32 (12) , 6445-6455
Abstract
The muscle membrane, sarcolemma, must be firmly attached to the basal lamina. The failure of proper attachment results in muscle injury, which is the underlying cause of Duchenne muscular dystrophy (DMD), in which mutations in the dystrophin gene disrupts the firm adhesion. In patients with DMD, even moderate contraction causes damage, leading to progressive muscle degeneration. The damaged muscles are repaired through myogenesis. Consequently, myogenesis is highly active in patients with DMD, and the repeated activation of myogenesis leads to the exhaustion of the myogenic stem cells. Therefore, approaches to reducing the risk of the exhaustion are to develop a treatment that strengthens the interaction between the sarcolemma and the basal lamina and increases the efficiency of the myogenesis. Galectin‐3 is an oligosaccharide‐binding protein and is known to be involved in cell–cell interactions and cell–matrix interactions. Galectin‐3 is expressed in myoblasts and skeletal muscle, although its function in muscle remains elusive. In this study, we found evidence that galectin‐3 and the monosaccharide N ‐acetylglucosamine, which increases the synthesis of binding partners (oligosaccharides) of galectin‐3, promote myogenesis in vitro. Moreover, in the mdx mouse model of DMD, treatment with N ‐acetylglucosamine increased muscle‐force production. The results suggest that treatment with N ‐acetylglucosamine might mitigate the burden of DMD.—Rancourt, A., Dufresne, S. S., St‐Pierre, G., Levesque, J.‐C., Nakamura, H., Kikuchi, Y., Satoh, M. S., Frenette, J., Sato, S. Galectin‐3 and N ‐acetylglucosamine promote myogenesis and improve skeletal muscle function in the mdx model of Duchenne muscular dystrophy. FASEB J. 32, 6445–6455 (2018). www.fasebj.orgKeywords
All Related Versions
This publication has 50 references indexed in Scilit:
- Cellular and molecular mechanisms underlying muscular dystrophyJournal of Cell Biology, 2013
- A comprehensive review of oral glucosamine use and effects on glucose metabolism in normal and diabetic individualsDiabetes/Metabolism Research and Reviews, 2010
- The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolismGenes & Development, 2010
- Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic responseJournal of Experimental Medicine, 2010
- Macrophages Protect against Muscle Atrophy and Promote Muscle Recovery in Vivo and in VitroThe American Journal of Pathology, 2010
- Metabolism, Cell Surface Organization, and DiseaseCell, 2009
- Galectin-3 promotes lamellipodia formation in epithelial cells by interacting with complex N-glycans on α3β1 integrinJournal of Cell Science, 2009
- Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesisJournal of Experimental Medicine, 2007
- Metabolic homeostasis and tissue renewal are dependent on β1,6GlcNAc-branched N-glycansGlycobiology, 2007
- Integrin α3 subunit participates in myoblast adhesion and fusion in vitroDifferentiation, 2006